Invizyne Technologies Files Registration Statement with SEC for Public Offering
Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems, has announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) for a public offering of its common stock. The offering will consist of 4,300,000 shares of common stock priced at $4.00 per share, resulting in gross proceeds of $17.2 million.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
